Raphael Pharmaceutical Inc.
RAPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,855 | $16,717 | $31,551 | $34,065 |
| - Cash | $19 | $230 | $288 | $153 |
| + Debt | $41 | $0 | $0 | $0 |
| Enterprise Value | $4,877 | $16,487 | $31,263 | $33,912 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,509 | -$1,332 | -$3,317 | -$1,629 |
| % Margin | – | – | – | – |
| Net Income | -$1,519 | -$1,344 | -$3,358 | -$1,624 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.081 | -0.08 | -0.23 | -0.1 |
| % Growth | -1.1% | 65% | -130% | – |
| Operating Cash Flow | -$532 | -$1,203 | -$759 | -$1,418 |
| Capital Expenditures | $0 | $0 | -$2 | $0 |
| Free Cash Flow | -$532 | -$1,203 | -$761 | -$1,418 |